Testicular Shrinkage: When to See a Doctor

What Is Testicular Shrinkage and How Much Change Is Clinically Significant?

Testicular atrophy means one or both testes have decreased in volume relative to their prior baseline or to population norms. A normal adult testis measures 15 to 25 mL by orchidometer or ultrasound. Clinicians generally treat a reduction of 20% or more from baseline, or a volume below 12 mL in a post-pubertal male, as clinically significant and worth investigating.

Measuring Testicular Volume

The Prader orchidometer, a string of ellipsoid beads ranging from 1 to 25 mL, is the office standard. Scrotal ultrasound is more precise, measuring length, width, and depth, then applying the formula: volume = 0.71 × length × width × depth. Ultrasound values below 10 mL in adults have been linked to impaired sperm production in multiple studies, including a 2021 cohort published in the Journal of Urology.

Why Symmetry Matters

Unilateral atrophy (one testis smaller than the other) points to a local cause such as varicocele, prior epididymo-orchitis, or torsion. Bilateral atrophy more often reflects systemic causes: hormonal suppression, chronic illness, or alcohol-related damage. Noticing one side has clearly changed while the other has not is itself a reason to book an appointment within the week.

The Main Causes of Testicular Shrinkage

Several distinct mechanisms produce testicular atrophy, and the treatment depends entirely on which one is active.

Exogenous Androgen Use (TRT and Anabolic Steroids)

This is the most common reversible cause in men aged 25 to 50. Exogenous testosterone suppresses pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Without LH, Leydig cells stop producing intratesticular testosterone. Without FSH, Sertoli cells lose their primary driver of spermatogenesis. The result is both atrophy and reduced fertility.

The 2022 AUA Guideline on Testosterone Deficiency states directly: "Patients initiating testosterone therapy should be counseled that exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis and may result in testicular atrophy and infertility." [1]

Human chorionic gonadotropin (hCG) at 500 IU subcutaneously three times per week can partially preserve testicular volume during TRT by mimicking LH. A 2005 randomized controlled trial in the Journal of Clinical Endocrinology and Metabolism (N=29) showed co-administration of hCG with testosterone maintained intratesticular testosterone at levels sufficient to support spermatogenesis, whereas testosterone alone caused a 94% decline.

Varicocele

A varicocele is an abnormal dilation of the pampiniform venous plexus. Grade II and III varicoceles raise intratesticular temperature by 1.5 to 2.0°C, damaging both Leydig and Sertoli cells over time. Varicoceles occur in approximately 15% of all males and in up to 35% of men presenting with primary infertility, per data from the World Health Organization multicenter study.

Left-sided varicoceles predominate (80 to 90% of cases) because the left gonadal vein drains at a right angle into the left renal vein, creating higher hydrostatic pressure. Surgical repair (varicocelectomy) or percutaneous embolization can halt progression and, in many patients, partially restore volume within 6 to 12 months.

Epididymo-Orchitis and Mumps Orchitis

Bacterial epididymo-orchitis (often caused by Chlamydia trachomatis or Escherichia coli) produces inflammatory damage that can scar testicular parenchyma if treatment is delayed. Mumps orchitis, occurring in 20 to 30% of post-pubertal males infected with the mumps virus, is the classic infectious cause of bilateral testicular atrophy. A 2010 review in BMJ noted that 30 to 87% of men with unilateral mumps orchitis demonstrate ipsilateral testicular atrophy on follow-up.

Testicular Torsion (Prior or Incomplete)

Testicular torsion interrupts arterial blood flow. Even partial or intermittent torsion (intermittent torsion syndrome) can cause ischemic atrophy over months without a clear acute event. Any history of sudden-onset scrotal pain that resolved on its own deserves urologic evaluation, because an untreated contralateral predisposition may remain.

Hypothalamic-Pituitary Disorders and Hypogonadism

Secondary hypogonadism from pituitary tumors, hyperprolactinemia, Kallmann syndrome, or chronic opioid use suppresses LH and FSH in the same way exogenous androgens do. Serum LH below 1.7 IU/L in a man with low testosterone and small testes should prompt pituitary MRI to rule out adenoma, per the Endocrine Society's 2018 Clinical Practice Guideline on Male Hypogonadism. [2]

Alcohol Use Disorder and Liver Disease

Chronic heavy alcohol intake (generally defined as more than 14 standard drinks per week) directly suppresses Leydig cell function and raises estradiol through peripheral aromatization. A study of 75 men with alcohol-related cirrhosis published in Hepatology found testicular atrophy in 74% of subjects, with atrophy severity correlating with the degree of hepatic dysfunction.

Cryptorchidism and Congenital Causes

An undescended testis left uncorrected past age 18 months undergoes progressive germ cell loss. Even after successful orchiopexy, the affected testis may remain smaller than its contralateral partner. Orchiopexy before 12 months of age is associated with the best long-term volume outcomes, per the 2018 American Urological Association pediatric guideline. [3]

Red Flags: When Testicular Shrinkage Requires Urgent or Emergency Care

Not every case needs same-day attention. The following signs change that calculus entirely.

Symptoms That Warrant a Same-Day or Emergency Visit

• Sudden scrotal pain alongside shrinkage or swelling: rule out torsion. Testicular salvage rates fall from 90% at 6 hours to under 10% at 24 hours after torsion onset. [4]
• A painless, firm lump on the surface of a testis: testicular cancer presents this way in approximately 90% of cases. Germ cell tumors account for 95% of testicular malignancies, with peak incidence in men aged 15 to 35. [5]
• Fever above 38.5°C plus scrotal pain: consistent with epididymo-orchitis or abscess, requiring antibiotics or drainage.
• Rapid bilateral atrophy over weeks: may indicate aggressive systemic disease or secondary hypogonadism from a pituitary mass.

Symptoms That Warrant a Same-Week Appointment

• Unilateral shrinkage noticed over 3 to 6 months without an obvious cause.
• Shrinkage accompanied by new erectile dysfunction or loss of morning erections.
• Shrinkage in a man currently on TRT who wants to preserve fertility.
• Any scrotal heaviness or dull ache lasting more than two weeks.

A useful clinical decision rule: if you can identify a clear, ongoing cause (for example, you started testosterone cypionate 6 months ago and your provider explained atrophy would occur), monitoring with your prescribing clinician is appropriate. If shrinkage appeared without an identifiable cause, prompt evaluation is warranted regardless of the absence of pain.

How Testicular Shrinkage Is Diagnosed

Diagnosis requires combining a targeted history, physical examination, imaging, and laboratory testing. No single test is sufficient.

History and Physical Examination

The clinician will ask about the timeline of volume change, any prior scrotal trauma or surgery, infection history, medication use (including anabolic steroids, opioids, and chemotherapy agents), alcohol intake, and fertility goals. Physical examination includes palpation for lumps, assessment of epididymis tenderness, presence of a varicocele (detected as a "bag of worms" sensation when the patient stands and performs a Valsalva maneuver), and orchidometer measurement.

Scrotal Ultrasound

Scrotal Doppler ultrasound is the imaging study of choice. It quantifies testicular volume bilaterally, identifies microlithiasis, masses, or vascular abnormalities, and measures blood flow to detect torsion or inflammation. The American College of Radiology recommends scrotal ultrasound as the first-line imaging modality for any palpable scrotal abnormality. [6]

Hormone Laboratory Panel

A minimum initial panel includes:

• Morning total testosterone (drawn between 7 and 10 AM on two separate days if the first result is low).
• LH and FSH: low values with low testosterone confirm secondary hypogonadism; high values with low testosterone confirm primary testicular failure.
• Prolactin: hyperprolactinemia is the most common pituitary cause of secondary hypogonadism and can be treated with cabergoline.
• Estradiol: elevated in aromatase-excess states and liver disease.
• Semen analysis: when fertility is a concern.

The Endocrine Society guideline specifies a testosterone threshold of 264 ng/dL (9.2 nmol/L) as the lower limit of normal, with clinical symptoms required before initiating treatment. [2]

When Pituitary MRI Is Indicated

MRI of the sella turcica with gadolinium contrast is indicated when LH and FSH are low or low-normal in the setting of testosterone below 150 ng/dL, or when prolactin exceeds 25 ng/mL. Pituitary adenomas larger than 1 cm (macroadenomas) require neurosurgical and endocrinologic co-management.

Treatment Options for Testicular Shrinkage

Treatment is cause-directed. There is no medication that directly enlarges a testis. The goal is to remove or correct the underlying cause and allow natural recovery.

Stopping or Modifying Exogenous Androgen Use

For TRT-induced atrophy, options include:

• Adding hCG: as noted above, 500 IU three times weekly has been shown to maintain intratesticular testosterone. Some protocols use 1,000 to 1,500 IU twice weekly during TRT.
• Post-cycle recovery with SERMs: after stopping anabolic steroids, clomiphene citrate 25 mg daily or tamoxifen 20 mg daily stimulates endogenous LH/FSH secretion. Recovery of testicular volume typically occurs over 3 to 6 months, though recovery can take up to 18 months in men who used supraphysiologic doses for several years.
• Gonadorelin (GnRH) pulsatile therapy: an emerging approach for men on TRT who want to maintain fertility, delivering GnRH in pulses to preserve pituitary responsiveness.

Varicocele Repair

Microsurgical subinguinal varicocelectomy is the current standard of care. A 2012 Cochrane systematic review (14 randomized trials, N=955) found varicocelectomy improved spontaneous pregnancy rates compared with no treatment (OR 2.23, 95% CI 1.46 to 3.42). [7] Testicular volume improvement has been documented at 6- and 12-month follow-up in multiple cohort studies.

Treating Infection

Bacterial epididymo-orchitis is treated based on likely organism. For sexually active men under 35, a regimen of ceftriaxone 500 mg intramuscularly once plus doxycycline 100 mg twice daily for 10 days (per CDC 2021 STI Treatment Guidelines) covers both gonorrhea and chlamydia. [8] Starting antibiotics within 48 hours of symptom onset significantly reduces the risk of permanent atrophy.

Secondary Hypogonadism: Stimulating Endogenous Production

When a pituitary adenoma is the cause, dopamine agonists (cabergoline 0.5 mg twice weekly for prolactinomas) often restore LH and FSH secretion within 3 to 6 months. For idiopathic hypogonadotropic hypogonadism, FSH plus hCG therapy can restore both testicular volume and fertility in the majority of patients when initiated promptly.

Lifestyle Modifications

Alcohol reduction to below 14 units per week (UK Chief Medical Officers' guideline) can partially restore hypothalamic-pituitary-gonadal axis function within 3 months in men with alcohol-related hypogonadism. Heat exposure from hot tubs, saunas used more than 3 times per week, and laptop use on the lap has been associated with elevated scrotal temperature and impaired spermatogenesis; reduction may help, though volume recovery data are limited.

Testicular Atrophy and Fertility: What the Evidence Shows

Volume is an imperfect but real predictor of fertility. A 2013 prospective study in Fertility and Sterility (N=214) found that total testicular volume below 20 mL bilaterally was associated with a 3.4-fold increase in the odds of oligozoospermia (sperm concentration below 15 million/mL). Men with bilateral atrophy and fertility goals should receive semen analysis before any hormonal intervention, because this baseline informs the urgency and choice of treatment.

Men on long-term TRT who have not preserved fertility with hCG and who want to father children face a recovery process. One cohort study published in JCEM (N=30) found that 90% of men recovered sperm in the ejaculate within 12 months of stopping testosterone, but recovery took a median of 3.4 months, with some requiring 18 months. Semen parameters rarely return fully to pre-treatment levels in men who used anabolic steroids for more than 3 years.

Testicular Shrinkage in Adolescents and Young Adults

Adolescent males with a varicocele and ipsilateral testicular atrophy (greater than 2 mL volume differential compared with the contralateral testis) are candidates for early varicocelectomy to protect long-term fertility. The American Society for Reproductive Medicine recommends intervention in adolescents when catch-up growth fails to occur within 12 months of watchful waiting. [9]

Painless unilateral atrophy appearing between ages 15 and 35 without a clear cause should raise concern for testicular cancer until ruled out by ultrasound and, if a mass is present, serum tumor markers (AFP, beta-hCG, LDH). Testicular cancer carries a 5-year survival rate above 95% when diagnosed at stage I, dropping to approximately 73% at stage III, per Surveillance, Epidemiology, and End Results (SEER) data from the National Cancer Institute. Early detection matters substantially.

Self-Monitoring: What to Check and How Often

Monthly testicular self-examination is endorsed by several urologic societies for men aged 15 to 35. The technique: standing after a warm shower, gently roll each testis between thumb and fingers, feeling for lumps, change in firmness, or a change in size compared with prior months. Any change noticed on two consecutive monthly self-exams warrants clinical evaluation rather than continued monitoring at home.

Men on TRT or anabolic steroid regimens should have testicular volume assessed by their prescribing clinician at every 6-month follow-up visit, along with morning testosterone, hematocrit, and PSA (in men over 40).